This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Hanmi Science Co., Ltd.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Ji Hyun Im: Innovator in Pharmaceutical Composition
Introduction
Ji Hyun Im is a notable inventor based in Suwon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of solid pharmaceutical compositions aimed at treating cardiovascular disorders. With a total of 2 patents, his work showcases innovative approaches to improving drug stability and efficacy.
Latest Patents
Ji Hyun Im's latest patents include a solid pharmaceutical composition comprising amlodipine and losartan with improved stability. This invention focuses on preventing or treating cardiovascular disorders by utilizing granular forms of amlodipine and losartan that are separated from each other, along with a stabilizing agent. This formulation enhances storage stability by minimizing the interaction between the two active ingredients. Another significant patent is a solid pharmaceutical composition comprising amlodipine and losartan, which includes a disintegrant made from a mixture of at least two components selected from sodium starch glycolate, crosscarmellose sodium, and crosspovidone. This composition exhibits high and stable dissolution rates for both amlodipine and losartan.
Career Highlights
Ji Hyun Im is currently associated with Hanmi Science Co., Ltd., a company known for its commitment to advancing pharmaceutical research and development. His work at Hanmi Science has been instrumental in pushing the boundaries of drug formulation and stability.
Collaborations
Throughout his career, Ji Hyun Im has collaborated with talented individuals such as Kyeong Soo Kim and Jae Hyun Park. These collaborations have fostered a creative environment that encourages innovation and the development of effective pharmaceutical solutions.
Conclusion
Ji Hyun Im's contributions to the pharmaceutical industry, particularly in the area of cardiovascular treatments, highlight his role as a key innovator. His patents reflect a commitment to improving drug stability and efficacy, making a significant impact in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile